Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Population Survey of Mantle Cell Lymphoma (MCL) in British Columbia (BC) – A Heterogeneous Disorder with Improved Outcomes in the Modern Era

Wendie-lou D. den Brok, MD, Kevin W. Song, MD, FRCPC, Hilary M. OLeary, MD, Richard Klasa, MD, Kerry J. Savage, MD MSc, Tamara Shenkier, MD, Diego Villa, MD, MPH, Graham W. Slack, MD, John D. Shepherd, MD, FRCPC, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Laurie H. Sehn, MD

Blood (2012) 120 (21): 1602.

https://doi.org/10.1182/blood.V120.21.1602.1602

Published: 2012

Journal Articles

Factors Predictive for Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia in a Population-Based Provincial Transplant Cohort

Chinmay B. Dalal, MD, Chandrakala Shanmukhaiah, MD, Thomas J. Nevill, MD, FRCPC, Michael J. Barnett, BMBS, FRCPC, FRCP, FRCPath, Stephen H. Nantel, MD, FRCPC, Donna E. Hogge, MD, PhD, FRCPC, Donna L. Forrest, MD, FRCPC, Heather J. Sutherland, MD, PhD, FRCPC, Kevin W. Song, MD, FRCPC, Raewyn Broady, MBChB, FRACP, Maryse M. Power, MD, MRCPI, FRCPath, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Yasser R Abou Mourad, MD, FRCPC, John D. Shepherd, MD, FRCPC, Sean S Young, PhD, DABMG, FACMG, FCCMG, Tanya L. Gillan, PhD, FCCMG, Cynthia L. Toze, MD, MHSc, FRCPC

Blood (2012) 120 (21): 4132.

https://doi.org/10.1182/blood.V120.21.4132.4132

Published: 2012

Journal Articles

Reduced Incidence of Early Invasive Fungal Infection in Allogeneic Transplant Patients Following Micafungin Prophylaxis

Derek To, Dawn Warkentin, BSc(Pharm), PharmD, Raewyn Broady, MBChB, FRACP, Kevin Song, MD, Michael J. Barnett, BMBS, Donna L. Forrest, MD, Thomas J. Nevill, MD, FRCPC, Stephen H. Nantel, MD, FRCPC, John D. Shepherd, MD, FRCPC, Donna E. Hogge, MD, PhD, Cynthia L. Toze, MD, FRCPC, Sujaatha Narayanan, MD, Yasser Abou Mourad, MD, Heather J. Sutherland, MD, PhD, FRCPC, Maryse M. Power, MD, FRCPath

Blood (2011) 118 (21): 4567.

https://doi.org/10.1182/blood.V118.21.4567.4567

Published: 2011

Journal Articles

Elderly AML Patients Treated with Intensive Chemotherapy- Developing A Prognostic Scoring System. A Study On 381 Patients From British Columbia

Satish Krishnan, MBBS, MRCP, FRCPath, Huihua Li, Yasser R Abou Mourad, Michael J. Barnett, BMBS, Raewyn Broady, MBChB, FRACP, Donna L. Forrest, MD, Stephen H. Nantel, MD, FRCPC, Sujaatha Narayanan, MD, Thomas J. Nevill, MD, FRCPC, Maryse M. Power, MD, FRCPath, John D. Shepherd, MD, FRCPC, Kevin W. Song, MD, Heather J. Sutherland, MD, PhD, FRCPC, Cynthia L. Toze, MD, FRCPC, Donna E. Hogge, MD, PhD

Blood (2011) 118 (21): 2561.

https://doi.org/10.1182/blood.V118.21.2561.2561

Published: 2011

Journal Articles

Outcomes for Patients Aged 60 and Over Are Similar to Younger Patients Following Reduced-Intensity Allogeneic Stem Cell Transplant for CLL

Cynthia L. Toze, MD, FRCPC, Chinmay B. Dalal, MD, Thomas J. Nevill, MD, FRCPC, Michael J. Barnett, BMBS, Stephen H. Nantel, MD, FRCPC, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Heather J. Sutherland, MD, PhD, FRCPC, Kevin W. Song, MD, Yasser Abou Mourad, MD, Raewyn Broady, MBChB, FRACP, Maryse M. Power, MD, FRCPath, Sujaatha Narayanan, MD, Tanya L. Gillan, PhD, FCCMG, Clayton A. Smith, MD, FRCPC, John D. Shepherd, MD, FRCPC

Blood (2011) 118 (21): 3100.

https://doi.org/10.1182/blood.V118.21.3100.3100

Published: 2011

Journal Articles

Chemoresistance Can Be Reliably Overcome with High-Dose Therapy and Autologous Stem Cell Transplantation (HDT/ASCT) for Relapsed and Refractory Hodgkin's Lymphoma

Alina S. Gerrie, MD, FRCPC, Maryse M. Power, MD, FRCPath, Kerry J. Savage, MD MSc, John D. Shepherd, MD, FRCPC, Joseph M. Connors, MD

Blood (2011) 118 (21): 2022.

https://doi.org/10.1182/blood.V118.21.2022.2022

Published: 2011

Journal Articles

Clonal Evolution but Not Variant Chromosomal Translocations Is An Adverse Prognostic Marker for Cytogenetic Response and Survival in CML Patients Treated with Imatinib

Adisak Tantiworawit, MD, Yasser Abou Mourad, MD, Michael J Barnett, BMBS, Raewyn Broady, MBChB, FRACP, Donna E. Hogge, MD, PhD, Stephen H. Nantel, MD, FRCPC, Sujaatha Narayanan, MD, Thomas J. Nevill, MD, FRCPC, Maryse M. Power, MD, FRCPath, John D. Shepherd, MD, FRCPC, Kevin W. Song, MD, Heather J. Sutherland, MD, PhD, FRCPC, Cynthia L. Toze, MD, FRCPC, Donna L. Forrest, MD

Blood (2011) 118 (21): 1694.

https://doi.org/10.1182/blood.V118.21.1694.1694

Published: 2011

Journal Articles

Allogeneic Stem Cell Transplant in First Complete Remission Overcomes the Poor Prognosis Associated with the FLT-3 Internal Tandem Duplication in Acute Myeloid Leukemia.

Maryse M. Power, MRCPI, MRCPath, Giovanna Di Sauro, Angela Brooks-Wilson, Thomas J. Nevill, MD, FRCPC, Julye C. Lavoie, MD, Clayton A. Smith, MD, John D. Shepherd, MD, FRCPC, Cindy L. Toze, MD, FRCPC, MHSc, Heather J. Sutherland, MD, FRCPC, PhD, Michael J. Barnett, MB, FRCPath, Yasser A. Abou Mourad, MD, Kevin W. Song, MD, FRCPC, Donna M. Forrest, MD, FRCPC, Steven H. Nantel, MD, FRCPC, Stanley C. Wong, Anna A. Krasnova, Ryan Brinkman, PhD, Donna E. Hogge, MD, PhD, FRCPC

Blood (2007) 110 (11): 3491.

https://doi.org/10.1182/blood.V110.11.3491.3491

Published: 2007

NARROW

Population Survey of Mantle Cell Lymphoma (MCL) in British Columbia (BC) – A Heterogeneous Disorder with Improved Outcomes in the Modern Era

Factors Predictive for Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia in a Population-Based Provincial Transplant Cohort

Reduced Incidence of Early Invasive Fungal Infection in Allogeneic Transplant Patients Following Micafungin Prophylaxis

Elderly AML Patients Treated with Intensive Chemotherapy- Developing A Prognostic Scoring System. A Study On 381 Patients From British Columbia

Outcomes for Patients Aged 60 and Over Are Similar to Younger Patients Following Reduced-Intensity Allogeneic Stem Cell Transplant for CLL

Chemoresistance Can Be Reliably Overcome with High-Dose Therapy and Autologous Stem Cell Transplantation (HDT/ASCT) for Relapsed and Refractory Hodgkin's Lymphoma

Clonal Evolution but Not Variant Chromosomal Translocations Is An Adverse Prognostic Marker for Cytogenetic Response and Survival in CML Patients Treated with Imatinib

Allogeneic Stem Cell Transplant in First Complete Remission Overcomes the Poor Prognosis Associated with the FLT-3 Internal Tandem Duplication in Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only